Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lipocine Inc (LPCN)

Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone PR Newswire - Tue Dec 16, 7:00AM CST

SALT LAKE CITY , Dec. 16, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective...

LPCN : 4.26 (+0.24%)
Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD) PR Newswire - Tue Nov 18, 7:00AM CST

SALT LAKE CITY , Nov. 18, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective...

LPCN : 4.26 (+0.24%)
Lipocine: Q3 Earnings Snapshot AP - Thu Nov 6, 7:12AM CST

Lipocine: Q3 Earnings Snapshot

LPCN : 4.26 (+0.24%)
Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2025 PR Newswire - Thu Nov 6, 7:00AM CST

SALT LAKE CITY , Nov. 6, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral...

LPCN : 4.26 (+0.24%)
Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek® PR Newswire - Tue Nov 4, 7:00AM CST

SALT LAKE CITY , Nov. 4, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective...

LPCN : 4.26 (+0.24%)
Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD) PR Newswire - Tue Sep 30, 7:00AM CDT

One-Third of Patients Randomized; Topline Results Expected in 2Q 2026

LPCN : 4.26 (+0.24%)
Lipocine to Present at H.C. Wainwright 27th Annual Global Investment Conference PR Newswire - Fri Sep 5, 3:30PM CDT

SALT LAKE CITY , Sept. 5, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...

LPCN : 4.26 (+0.24%)
Lipocine Announces LPCN 2101 Abstracts Accepted for Presentation at AES 2025 PR Newswire - Tue Aug 26, 7:00AM CDT

SALT LAKE CITY , Aug. 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...

LPCN : 4.26 (+0.24%)
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025 PR Newswire - Tue Aug 5, 7:00AM CDT

SALT LAKE CITY , Aug. 5, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with...

LPCN : 4.26 (+0.24%)
Lipocine: Q2 Earnings Snapshot AP - Tue Aug 5, 5:21AM CDT

Lipocine: Q2 Earnings Snapshot

LPCN : 4.26 (+0.24%)

Barchart Exclusives

Is This Soon-to-Be $1 Trillion Stock a Buy Now? Barchart - 33 minutes ago
The world’s biggest retailer is playing offense again. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot